Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Cell and Gene Therapy
Sort By
Newest First
1 / 20
1 / 20
AAV
Overcoming Variability and Scaling Challenges in AAV Manufacturing
Rafal Garus
Viralgen Vector Core
PAO-08-24-CL-03
July 22, 2024
Cell and Gene Therapy
Managing Complex Sample and IP Logistics in Support of Cell and Gene Therapies
Erin Schaller; Aidan Jones
PPD
PAO-06-24-CL-11
July 09, 2024
Cell Therapy
Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA
Genezen
PR-07-24-NI-01
July 02, 2024
Cell Therapy
Facilitating Organoid Production for Biopharmaceutical Applications
Karen Weisinger, Ph.D.
Cell X Technologies
PAO-06-24-CL-12
July 02, 2024
Synthetic DNA
Transforming the Economics of AAV Manufacture While Optimizing Quality with dbDNA
Tom Merritt, Ph.D.
Touchlight
PAO-07-24-CL-01
July 02, 2024
Protein Degradation
PROTACS: Upgrading Small Molecule Inhibitors
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-24-NI-02
June 11, 2024
Cell Therapy
Intelligent Cell Processing Enables Consistent, Reproducible, and Scalable GMP-Compliant Processes
Karen Weisinger, Ph.D.
Cell X Technologies
PAO-06-24-CL-07
May 30, 2024
Exosomes
Bright Outlook for Exosome-Based Therapeutics and Diagnostics Despite Numerous Hurdles
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-05-24-NI-01
May 09, 2024
Cell and Gene Therapy Regulatory
Navigating Regulatory Complexity for Cell and Gene Therapies
Natasha Rivas
PAO-04-24-CL-03
April 12, 2024
Manufacturing Partnership
Genezen Announces Strategic Process Development and Manufacturing Partnership Agreement with Seattle Children’s Research Institute for X-linked Agammaglobulinemia (XLA) Cell Therapy Program
Genezen
PR-M03-24-01-5831
March 06, 2024
Lentivirus Production
Genezen Enters Licensing Agreement with CSL for the Cytegrity™ Stable Lentivirus Production System
Genezen
PR-M02-05-02
February 21, 2024
Cell Therapy Manufacturing
Rethinking Cell Engineering for Cell Therapy Manufacturing
Todd Sulchek, Ph.D
CellFE
PAO-11-23-CL-03
December 13, 2023
Stem Cell Therapy
Designing A Recipe for Stem Cell Therapy Success
Ben Josey, Ph.D.; Robert Padilla
Corning Life Sciences
PTV-12-23-CL-01
December 12, 2023
Cell and Gene Therapy
Scaling Cell and Gene Therapy Processes from R&D to Production
Shawn Bates; Antonio Fernandez-Perez, Ph.D.
Corning Life Sciences
PAO-12-23-CL-03
December 12, 2023
Viral Vectors
Facing the Dual Scientific and Financial Challenges to Advance Cell and Gene Therapies
Jimmy Vanhove
Viralgen Vector Core
PAO-11-23-CL-02
November 28, 2023
Microbiome
Modifying the Gut Microbiome to Improve CAR-T, HSCT, and Other Therapeutic Responses
Stacy Burns-Guydish, Ph.D.
List Labs
PAO-10-23-CL-07-33
November 01, 2023
Digitalization, AI, and Automation
Digitalization, AI, and Automation Lead Pack of Advances Fueling Life Sciences Industry Growth, New CRB Report Finds
CRB
PR-M10-23-05
October 19, 2023
Cell and Gene Therapy Distribution
Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies
Be The Match BioTherapies
PR-M10-23-03-44
October 13, 2023
Cell and Gene Therapy
View from the Top: Cell and Gene Therapy Successes and Promise
David Alvaro, Ph.D.
Pharma's Almanac
PAO-08-23-NI-01
October 03, 2023
Cell Therapy
Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support
Sarah Meeks, Ph.D.
MaxCyte
PAO-09-23-CL-09
September 28, 2023